权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases

动脉粥样硬化和心脏代谢疾病中的巨噬细胞功能障碍

基本信息

批准号：
10616525
负责人：
Edward A Fisher
金额：
$ 256.79万
依托单位：
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-05-01 至 2027-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10616525
关键词：
Adipocytes Adipose tissue Adverse effects Arterial Fatty Streak Atherosclerosis Binding Biochemistry Bioinformatics Biological Availability Biometry Bone Marrow Breeding Caloric Restriction Cardiometabolic Disease Cardiovascular Diseases Cell Communication Cells Clinical Trials Communication Complex Cues Cytoplasm Databases Deposition Diabetes Mellitus Employment Endotoxins Fostering Functional disorder Funding High Fat Diet Home Human Immune Immune response Infiltration Inflammation Inflammatory Insulin Resistance Kupffer Cells LXRalpha protein Lipids Liver Macrophage Mediating Mediation Mediator Metabolic Metabolic dysfunction Metabolism Molecular Mus Myelogenous NTN1 gene Nervous System Obesity Organ Pathologic Pathology Patients Pattern Phosphorylation Play Procedures Process Program Research Project Grants Regulation Resolution Shapes Signal Pathway Site Stimulus Therapeutic Thermogenesis Tissues Work atherosclerosis risk cardiometabolism cardiovascular disorder risk cardiovascular risk factor clinically significant comorbidity experience forging human tissue imprint in vivo inhibitor insight nonalcoholic steatohepatitis novel novel therapeutic intervention programs receptor recruit remediation response therapeutic target trafficking transcription factor transcriptome

项目摘要

Summary: Overall This Program Project grant has unveiled key roles for macrophage metabolism, depot- and cue-dependent molecular re-programming and intraorgan communications in cardiometabolic dysfunction. The Program Project team will build upon these discoveries and forge new directions. Macrophages mediate intraorgan communications and, through interorgan communications, macrophages and other bioactive mediators home to and infiltrate distinct sites, such as in the atherosclerotic plaque; in obese adipose tissue; and to be newly explored in this Cycle; in the liver. In cardiometabolic dysfunction, the liver is the recipient of increased endotoxin from the gut; accumulation of lipid from adipose tissue; and increased bioavailability of damage-associated molecular patterns. In each metabolic organ, the tissue-specific niche defines the myriad consequences, such as excess synthesis/deposition of pathological lipids; and recruitment of infiltrating bone marrow-derived immune cells. These delivered stimuli modulate endogenous signaling pathways in resident adipose tissue macrophages and liver Kupffer cells and impart immunometabolic imprints on macrophage subsets in atherosclerosis, obesity and non-alcoholic steatohepatitis (NASH). These concepts are clinically-significant, as atherosclerosis, obesity and NASH are established risk factors for cardiovascular diseases. The Program Project will explore three specific aims: First, Aim 1 (Project 1) will determine the mechanisms by which caloric restriction mediates macrophage intra- and interorgan communications in atherosclerosis, obesity and NASH, and define the impact of LXRα phosphorylation in liver immune cells on NASH-related factors under study in each Project. Second, Aim 2 (Project 2) will probe the mechanisms by which netrin-1 and its receptor network mediate macrophage intra- and interorgan communications in atherosclerosis, obesity and NASH. Third, Aim 3 (Project 3) will probe the mechanisms by which RAGE/DIAPH1 mediates macrophage intra- and interorgan communications in atherosclerosis, obesity and NASH. The Program Project will be supported by three cores: Core A (Administrative, which includes Biostatistics and Bioinformatics); Core B (Pathology and Biochemistry); and Core C (Mouse Breeding and Procedure Core). Collectively, this highly-motivated Program Project team continues to work together synergistically to interrogate novel mechanisms by which macrophage intraorgan and interorgan communications contribute to the mediation and remediation of cardiometabolic disease. Through the employment of state-of-the-art approaches and shared complementary examinations in human tissues and human transcriptome databases, this Program Project will discover new mechanistic insights that lead to therapeutic approaches to quench the exaggerated macrophage accumulation, inflammation and intra/interorgan communications that amplify cardiovascular risk.

摘要：总体这项计划项目拨款揭示了巨噬细胞代谢的关键作用，仓库和线索依赖心脏代谢功能障碍中的分子重编程和器官内通讯。方案项目团队将在这些发现的基础上开拓新的方向。巨噬细胞介导的器官内通讯，并通过器官间通讯，巨噬细胞和其他生物活性介质回家，并浸润不同的部位，如动脉粥样硬化斑块中;肥胖脂肪组织中;以及在这个循环中探索;在肝脏中。在心脏代谢功能障碍中，肝脏是增加的内毒素的接受者从肠道;脂肪组织的脂质积累;和增加的生物利用度的损害相关的分子模式在每个代谢器官中，组织特异性生态位定义了无数的后果，例如病理性脂质的过度合成/沉积;以及浸润性骨髓源性免疫的募集，细胞这些传递的刺激调节驻留脂肪组织巨噬细胞中的内源性信号传导途径和肝枯否细胞，并在动脉粥样硬化、肥胖症、非酒精性脂肪性肝炎（NASH）这些概念具有临床意义，如动脉粥样硬化、肥胖和NASH是心血管疾病的既定危险因素。该项目将探索三个具体目标：首先，目标1（项目1）将确定热量限制介导巨噬细胞在动脉粥样硬化、肥胖和NASH中的器官内和器官间通讯，每个项目中正在研究的肝脏免疫细胞中LXRα磷酸化对NASH相关因子的影响。第二、目的2（项目2）探讨netrin-1及其受体网络介导巨噬细胞凋亡的机制动脉粥样硬化、肥胖和NASH中的器官内和器官间通讯。第三，目标3（项目3）将探索 CD 4/DIAPH 1介导巨噬细胞器官内和器官间通讯的机制，动脉粥样硬化、肥胖和NASH。该计划项目将由三个核心支持：核心A （行政管理，包括生物统计学和生物信息学）;核心B（病理学和生物化学）;和核心 C（小鼠育种和程序核心）。总的来说，这个高度积极的计划项目团队继续协同工作，询问器官内和器官间巨噬细胞交流有助于心脏代谢疾病的调解和补救。通过在人体组织中采用最先进的方法和共享互补检查，人类转录组数据库，这个计划项目将发现新的机制的见解，导致治疗方法，以淬火夸张的巨噬细胞积累，炎症和放大心血管风险的器官内/器官间通信。

项目成果

期刊论文数量（13）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Diabetes and Metabolic Drivers of Trained Immunity: New Therapeutic Targets Beyond Glucose.

培训免疫的糖尿病和代谢驱动因素：葡萄糖以外的新治疗靶标。

DOI：
10.1161/atvbaha.120.314211
发表时间：
2021-04
期刊：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
影响因子：
8.7
作者：
Choudhury, Robin P.;Edgar, Laurienne;Ryden, Mikael;Fisher, Edward A.
通讯作者：
Fisher, Edward A.

The receptor for advanced glycation end products (RAGE) and DIAPH1: unique mechanisms and healing the wounded vascular system.

晚期糖基化终末产物 (RAGE) 和 DIAPH1 的受体：独特的机制和治愈受伤的血管系统。

DOI：
10.1080/14789450.2018.1536551
发表时间：
2019
期刊：
Expert review of proteomics
影响因子：
3.4
作者：
Ramasamy,Ravichandran;Friedman,RichardA;Shekhtman,Alexander;Schmidt,AnnMarie
通讯作者：
Schmidt,AnnMarie

Obesity research: Moving from bench to bedside to population.